Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference48 articles.
1. International incidence rates of invasive cervical cancer after introduction of cytological screening;Gustafsson;Cancer Causes Control,1997
2. A controlled trial of a human papillomavirus type 16 vaccine;Koutsky;N Engl J Med,2002
3. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial;Harper;Lancet,2004
4. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial;Villa;Lancet Oncol,2005
5. Sustained efficacy up to 4.5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial;Harper;Lancet,2006
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer;Journal of Cancer Research and Clinical Oncology;2024-06-25
2. Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study;International Immunopharmacology;2024-03
3. WITHDRAWN: LncRNA MIR497HG inhibits cervical cancer by upregulating BCL6B to block PI3K/AKT signaling;Biochemical and Biophysical Research Communications;2024-02
4. Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?;Frontiers in Immunology;2024-01-29
5. Penpulimab and anlotinib in an elderly patient with recurrent cervical cancer: a case report and literature review;Immunotherapy;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3